Swiss National Bank
TYRA icon

Swiss National Bank’s Tyra Biosciences TYRA Stock Holding History

Swiss National Bank’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Buy
44,700
+18,300
+69% +$605K ﹤0.01% 2088
2026
Q1 		$1.01M Buy
+26,400
New +$855K ﹤0.01% 2152
2025
Q2 		– Sell
-29,400
Closed -$273K – 2398
2025
Q1 		$273K Buy
29,400
+8,700
+42% +$113K ﹤0.01% 2389
2024
Q4 		$288K Sell
20,700
-5,000
-19% -$90.7K ﹤0.01% 2433
2024
Q3 		$604K Buy
+25,700
New +$540K ﹤0.01% 2391

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Swiss National Bank's TYRA Position: Q2 2026 in Review

Swiss National Bank increased its Tyra Biosciences (TYRA) stake by 69% in Q2 2026, buying an estimated $605K and bringing the position to 44,700 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2088.

Swiss National Bank first reported a position in TYRA in Q3 2024 and has held it in 5 quarters since. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Swiss National Bank held 44,700 shares of Tyra Biosciences worth $1.43M as of Q2 2026.
  • Swiss National Bank bought 18,300 Tyra Biosciences shares in Q2 2026, an estimated $605K.
  • Tyra Biosciences made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #2088 holding.
  • Swiss National Bank first reported a position in Tyra Biosciences in Q3 2024 and has held it in 5 quarters since.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.